Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Cost of Revenue

$1.25B

TTM · Period ending: Jun 30, 2026 · USD

BIO Cost of Revenue

Latest reported$1.25Bperiod endingJun 30, 2026

BIO TTM Cost of Revenue ($0.00 → $1.25B)

TTM cost of revenue

High-resolution chart · PNG

BIO cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock Cost of Revenue — Trailing twelve months (TTM) (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2026	1,245,500,000
Mar 31, 2026	1,246,600,000
Dec 31, 2025	1,243,300,000
Sep 30, 2025	1,220,863,000
Jun 30, 2025	1,205,089,000
Mar 31, 2025	1,181,546,000
Dec 31, 2024	1,186,500,000
Sep 30, 2024	1,176,221,000
Jun 30, 2024	1,178,836,000
Mar 31, 2024	1,214,706,000
Dec 31, 2023	1,244,779,000
Sep 30, 2023	1,262,686,000
Jun 30, 2023	1,273,253,000
Mar 31, 2023	1,249,744,000
Dec 31, 2022	1,232,744,000
Sep 30, 2022	1,231,321,000
Jun 30, 2022	1,233,927,000
Mar 31, 2022	1,253,142,000
Dec 31, 2021	1,281,884,000
Sep 30, 2021	1,279,800,000
Jun 30, 2021	1,250,138,000
Mar 31, 2021	1,179,697,000
Dec 31, 2020	1,107,804,000
Sep 30, 2020	1,072,109,000
Jun 30, 2020	1,045,764,000
Mar 31, 2020	1,066,722,000
Dec 31, 2019	1,054,663,000
Sep 30, 2019	1,044,439,000
Jun 30, 2019	1,049,254,000
Mar 31, 2019	1,058,648,000
Dec 31, 2018	1,065,747,000
Sep 30, 2018	1,062,822,000
Jun 30, 2018	1,034,883,000
Mar 31, 2018	992,006,000
Dec 31, 2017	972,754,000
Sep 30, 2017	949,010,000
Jun 30, 2017	947,803,000
Mar 31, 2017	952,981,000
Dec 31, 2016	930,085,000
Sep 30, 2016	935,031,000
Jun 30, 2016	912,264,000
Mar 31, 2016	902,224,000
Dec 31, 2015	897,771,000
Sep 30, 2015	916,543,000
Jun 30, 2015	952,102,000
Mar 31, 2015	965,187,000
Dec 31, 2014	996,527,000
Sep 30, 2014	995,599,000
Jun 30, 2014	974,381,000
Mar 31, 2014	960,011,000
Dec 31, 2013	954,216,000
Sep 30, 2013	927,116,000
Jun 30, 2013	931,453,000
Mar 31, 2013	928,755,000
Dec 31, 2012	908,190,000
Sep 30, 2012	894,676,000
Jun 30, 2012	889,827,000
Mar 31, 2012	895,825,000
Dec 31, 2011	895,640,000
Sep 30, 2011	890,365,000
Jun 30, 2011	875,199,000
Mar 31, 2011	846,033,000
Dec 31, 2010	835,630,000
Sep 30, 2010	828,237,000
Jun 30, 2010	823,610,000
Mar 31, 2010	809,477,000
Dec 31, 2009	784,401,000
Sep 30, 2009	759,086,000
Jun 30, 2009	759,841,000
Mar 31, 2009	778,560,000
Dec 31, 2008	801,843,000
Sep 30, 2008	826,609,000
Jun 30, 2008	776,694,000
Mar 31, 2008	721,877,000
Dec 31, 2007	669,690,000
Sep 30, 2007	601,159,000
Jun 30, 2007	587,749,000
Mar 31, 2007	571,711,000
Dec 31, 2006	561,394,000
Sep 30, 2006	548,532,000
Jun 30, 2006	536,970,000
Mar 31, 2006	534,544,000
Dec 31, 2005	534,499,000
Sep 30, 2005	529,370,000
Jun 30, 2005	518,993,000
Mar 31, 2005	499,219,000
Dec 31, 2004	482,320,000
Sep 30, 2004	460,137,000
Jun 30, 2004	454,382,000
Mar 31, 2004	450,600,000
Dec 31, 2003	437,990,000
Sep 30, 2003	426,795,000
Jun 30, 2003	412,366,000
Mar 31, 2003	397,649,000
Dec 31, 2002	383,235,000
Sep 30, 2002	376,562,000
Jun 30, 2002	360,628,000
Mar 31, 2002	353,854,000
Dec 31, 2001	346,028,000
Sep 30, 2001	321,028,000